Canada Life
IMVT icon

Canada Life’s Immunovant IMVT Stock Holding History

Canada Life’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$259K Buy
10,360
+4,373
+73% +$113K ﹤0.01% 1570
2025
Q4 		$152K Hold
5,987
– – ﹤0.01% 1661
2025
Q3 		$96K Hold
5,987
– – ﹤0.01% 1765
2025
Q2 		$96K Hold
5,987
– – ﹤0.01% 1770
2025
Q1 		$102K Sell
5,987
-8,289
-58% -$173K ﹤0.01% 1777
2024
Q4 		$353K Buy
14,276
+8,289
+138% +$235K ﹤0.01% 1691
2024
Q3 		$171K Sell
5,987
-9,416
-61% -$278K ﹤0.01% 1793
2024
Q2 		$406K Buy
15,403
+3,072
+25% +$87.4K ﹤0.01% 1718
2024
Q1 		$398K Buy
12,331
+6,344
+106% +$231K ﹤0.01% 1733
2023
Q4 		$251K Buy
5,987
+845
+16% +$31.1K ﹤0.01% 1802
2023
Q3 		$197K Buy
5,142
+2,782
+118% +$62.9K ﹤0.01% 1863
2023
Q2 		$45K Hold
2,360
– – ﹤0.01% 2012
2023
Q1 		$37K Hold
2,360
– – ﹤0.01% 2112
2022
Q4 		$42K Hold
2,360
– – ﹤0.01% 2106
2022
Q3 		$13K Hold
2,360
– – ﹤0.01% 2311
2022
Q2 		$9K Hold
2,360
– – ﹤0.01% 2373
2022
Q1 		$14K Hold
2,360
– – ﹤0.01% 2401
2021
Q4 		$20K Hold
2,360
– – ﹤0.01% 2379
2021
Q3 		$21K Hold
2,360
– – ﹤0.01% 2426
2021
Q2 		$25K Hold
2,360
– – ﹤0.01% 2439
2021
Q1 		$38K Buy
2,360
+560
+31% +$14.8K ﹤0.01% 2378
2020
Q4 		$83K Hold
1,800
– – ﹤0.01% 2153
2020
Q3 		$63K Hold
1,800
– – ﹤0.01% 2130
2020
Q2 		$43K Buy
+1,800
New +$38.6K ﹤0.01% 2262

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Canada Life's IMVT Position: Q1 2026 in Review

Canada Life increased its Immunovant (IMVT) stake by 73% in Q1 2026, buying an estimated $113K and bringing the position to 10,360 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

Canada Life first reported a position in IMVT in Q2 2020 and has held it in 24 quarters since. The position peaked at $406K in Q2 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Canada Life held 10,360 shares of Immunovant worth $259K as of Q1 2026.
  • Canada Life bought 4,373 Immunovant shares in Q1 2026, an estimated $113K.
  • Immunovant made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1570 holding.
  • Canada Life first reported a position in Immunovant in Q2 2020 and has held it in 24 quarters since.
  • Canada Life's Immunovant position peaked at $406K in Q2 2024.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.